EGFR and Nephropathy: Interestingly, in contrast to other EGFR ligands discussed above, NRG-1 (neuregulin-1) has been reported to be reno-protective in a model of type 1 diabetes bearing a mild form of nephropathy with significant cardiovascular dysfunction (Vandekerckhove et al., 2016).